Christopher A. Kuebler, Director at NEKTAR THERAPEUTICS (NKTR), sold 40,000 shares at $97.41 ($3.9M) on 2018-03-07, disclosed to the SEC on 2018-03-08.
Open-market sale of $3.9M NKTR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.30 | 2,600 | $261K | 6.7% |
| 2 | $97.41 | 37,400 | $3.6M | 93.3% |
| Total | $97.60 avg | 40,000 | $3.9M | 100% |
| Filing → |
| WAT | SELL | 2023-08-07 | $1.2M | — | Filing → |
| WAT | SELL | 2022-05-23 | $1.3M | — | Filing → |
| WAT | SELL | 2021-08-19 | $1.2M | — | Filing → |